One of our core missions is to research survivorship issues during and after treatment ​for cancer and test interventions to improve quality of life and outcomes.

current research

previous research

related publications

Current Research

The role of cytomegalovirus (CMV) and inflammation on patient symptoms and outcomes in ovarian cancer

In the United States, over 20,000 women are diagnosed with ovarian cancer annually. Surgery and chemotherapy often result in prolonged side effects. Cytomegalovirus (CMV), a widely prevalent virus in the general US population, has been shown to be associated with increased inflammation and mortality.

We are partnering with the Department of Defense - Ovarian Cancer Academy and Minnesota Ovarian Cancer Alliance (MOCA) to determine the relationship between CMV and ovarian cancer patient-reported symptoms after receiving chemotherapy, including fatigue and changes in cognitive functioning, often termed "chemo brain".

Status: We have completed recruiting participants and are finishing collecting data. We anticipate starting analyses Summer 2024.

Dr. Vogel received grant funding from the Department of Defense - Ovarian Cancer Academy and Minnesota Ovarian Cancer Alliance to support this research.

Current Research

Minnesota Immunotherapy eXperience Study

Immunotherapies have been a recent therapeutic success story and are becoming a mainstay in cancer. But ​studying their long-term effects on quality of life is still new.

We are conducting a longitudinal survey in Minnesota to help us identify long-term side effects and areas for future ​research for people who have been treated with immunotherapies. Participants who have been diagnosed with ​cancer and treated with immunotherapies within the MHealth Fairview System complete a couple surveys a year to ​provide feedback.

Status: We are currently recruiting participants and collecting data.

Dr. Vogel received grant funding from the Masonic Cancer Center and ​the Departments of Obstetrics, Gynecology and Women's Health and ​Hematology, Oncology and Transplantation to support this research.

Previous Research

Gynecologic Oncology - Life after Diagnosis (GOLD) Study

We created the University of Minnesota Gynecologic Oncology – Life after ​Diagnosis (GOLD) Research Program to optimize the health of individuals ​diagnosed with and treated for gynecologic cancers.

The goal of GOLD Research Program was to promote and facilitate research aimed ​to understand survivorship issues during and after treatment for gynecologic ​cancers and to improve survivors’ quality of life and outcomes. This study resulted ​in 11 manuscripts and 9 presentations.

We received grant funding from the Masonic ​Cancer Center to support this research.

Related Publications

• Johnson AM, Teoh D, Jewett P, Darst BF, Mattson J, Hoffmann C, Brown K, Makaram A, Keller C, Blaes AH, Everson-Rose SA, Vogel RI. Genetic variants ​associated with post-traumatic stress symptoms in patients with gynecologic cancer. Gynecol Oncol. 2023 Jan 19;170:102-107. doi: ​10.1016/j.ygyno.2023.01.006.
  

• Mell CA, Jewett PI, Teoh D, Vogel RI, Everson-Rose SA. Psychosocial predictors of fear of cancer recurrence in a cohort of gynecologic cancer survivors. ​Psychooncology. 2022 Dec;31(12):2141-2148. doi: 10.1002/pon.6055.

• Stenzel AE, Thomaier L, Jewett PI, Dona AC*, Brown K, Gotlieb R, Blaes A, Teoh D, Vogel RI. Interactions between physical activity and type of cancer ​treatment received on associations with psychosocial outcomes among gynecologic cancer survivors. Gynecol Oncol. 2022 Jul;166(1):85-89. doi: ​10.1016/j.ygyno.2022.04.019.
  

• Quam N, Stenzel AE, Brown K, Jewett P, Parsons HM, Hui J, Ghebre RG, Blaes A, Teoh D, Vogel RI. Perception of Telehealth During the COVID-19 ​Pandemic Among Survivors of Gynecologic Cancer. Oncologist. 2022 Jun 8;27(6):512-515. doi: 10.1093/oncolo/oyac041.

• Jewett PI, Vogel RI, Galchutt P, Everson-Rose SA, Teoh D, Radomski M, Blaes AH. Associations between a sense of connection and existential and ​psychosocial outcomes in gynecologic and breast cancer survivors. Support Care Cancer. 2022 Apr;30(4):3329-3336. doi: 10.1007/s00520-021-06784-8
  

• Thomaier L, Darst BF, Jewett P, Hoffmann C, Brown K, Makaram A, Blaes A, Argenta P, Teoh D, Vogel RI. Genetic variants predictive of chemotherapy-​induced peripheral neuropathy symptoms in gynecologic cancer survivors. Gynecol Oncol. 2021 Dec;163(3):578-582. doi: 10.1016/j.ygyno.2021.10.006.
  

• Schefter A, Thomaier L, Jewett P, Brown K, Stenzel AE, Blaes A, Teoh D, Vogel RI. Cross-sectional study of psychosocial well-being among lesbian, gay, ​bisexual and heterosexual gynecologic cancer survivors. Cancer Rep (Hoboken). 2022 Feb;5(2):e1461. doi: 10.1002/cnr2.1461.

Related Publications continued

• Messelt A, Thomaier L, Jewett PI, Lee H, Teoh D, Everson-Rose SA, Blaes AH, Vogel RI. Comparisons of emotional health by diagnosis among women ​with early stage gynecological cancers. Gynecol Oncol. 2021 Mar;160(3):805-810. doi: 10.1016/j.ygyno.2020.12.019.
  

• Wesley E, Uppendahl LD, Felices M, Dahl C, Messelt A, Boylan KLM, Skubitz APN, Vogel RI, Nelson HH, Geller MA. Cytomegalovirus and systemic ​inflammation at time of surgery is associated with worse outcomes in serous ovarian cancer. Gynecol Oncol. 2021 Jan;160(1):193-198. doi: ​10.1016/j.ygyno.2020.10.029.

• Lou E, Teoh D, Brown K, Blaes A, Holtan SG, Jewett P, Parsons H, Mburu EW, Thomaier L, Hui JYC, Nelson HH, Vogel RI. Perspectives of cancer patients ​and their health during the COVID-19 pandemic. PLoS One. 2020 Oct 30;15(10):e0241741. doi: 10.1371/journal.pone.0241741.

• Thomaier L, Jewett P, Brown K, Gotlieb R, Teoh D, Blaes AH, Argenta P, Vogel RI. The associations between physical activity, neuropathy symptoms ​and health-related quality of life among gynecologic cancer survivors. Gynecol Oncol. 2020 Aug;158(2):361-365. doi: 10.1016/j.ygyno.2020.05.026.

• Jewett PI, Teoh D, Petzel S, Lee H, Messelt A, Kendall J, Hatsukami D, Everson-Rose SA, Blaes AH, Vogel RI. Cancer-Related Distress: Revisiting the ​Utility of the National Comprehensive Cancer Network Distress Thermometer Problem List in Women With Gynecologic Cancers. JCO Oncol Pract. ​2020 Aug;16(8):e649-e659. doi: 10.1200/JOP.19.00471.

• Parsons HM, Jewett PI, Sadak K, Turcotte LM, Vogel RI, Blaes AH. e-Cigarette Use Among Young Adult Cancer Survivors Relative to the US Population. ​JAMA Oncol. 2020 Jun 1;6(6):923-926. doi: 10.1001/jamaoncol.2020.0384.